Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore what constitutes a leading economic indicator, why it matters, and how analysts use it to anticipate shifts in the economy.
10,046 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
South Korea’s Kiwoom Securities is nearing a deal to take a minority stake in Bithumb, signaling growing institutiona...
Elon Musk publicly weighs in on Mackenzie Scott’s $26 billion giving, sparking a larger debate about the effectivenes...
Looking to add real estate exposure to your portfolio? This guide compares state street's xtrackers' hauz with a broa...
Memory markets have swung on supply timing. This article breaks down what micron's says this when means for pricing p...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...
Stocks of Intel, AMD and Taiwan Semiconductor slid as Bank of America warned that bubble risk may be rising in the AI...
Brookfield Asset Management is expanding its AI infrastructure pact with Bloom Energy to $25 billion, signaling a maj...
Two Harbors Investment Corp. shareholders approved an all-cash sale to CCM at $12 per share, ending a months-long bid...
A historic clash over openness in software mirrors today’s AI debate, with investors watching who controls code, data...
A fresh analysis shows WisdomTree's WCLD underperforms due to equal-weight rebalancing, turning a $10,000 stake into ...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...